Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis
NCT00003853Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1999
- Primary completion
- Aug 2000
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of iododoxorubicin in primary systemic amyloidosis, sponsored by National Cancer Institute. Started Apr 1999; status: completed.
02
Drugs
iododoxorubicin
03
Conditions
primary systemic amyloidosis
Beyond the preview
Go deeper on NCT00003853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003853.